Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0003864 (
arthritis
)
69,039
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Rheumatism in its many forms has affected mankind since ancient times. Numerous examples exist of the powerful and the famous who suffered these afflictions. In some cases the disease process in thought to have, through the sufferers, altered the course of history itself. Throughout history, the arts have served as a means by which man expressed life's broad range of emotions: love, beauty,
despair
, loneliness. But the works of several prominent artists also reflect the pain and frustration of
arthritis
. Examples of common diseases include low back pain and sciatica, which disabled Aneas of Greek mythology, Jacob of Biblical times, Sister Catherine and Jefferson. Lincoln and Paganini are both thought to have suffered from Marfan's syndrome. Ankylosing spondylitis affected Cosimo de Medici and the poet Scarron, while the disability of Columbus is thought to be more compatible with Reiter's Syndrome. Without even considering the numerous examples of famous personnages who had gout, one can find multiple historical and artistic figures who suffered from chronic polyarthritis. A brief list would include the Emperor Constantine, Rubens, Mary Queen of Scots, Madison, Renoir, Verlaine, and Dufy. Since these disorders can also be found in historical references, one wonders if, having affected the lives and temperaments of the eminent, the powerful, or an entire population, they may have in some circumstances exerted some influence on the course of world history, or, through artistic talents, contributed to the intellectual enrichment of society.
...
PMID:The past: a gallery of arthritics. 269 46
Global health estimates indicated approximately 322 million people living with depression. Rising cost of depressive illness treatment and non-responsiveness to existing therapies demand continued research to explore new and more potent therapies. Exploring the potential of natural compounds for their potent antidepressant potentials is becoming topic of interest for scientists. Anti-inflammatory activity of thymoquinone, the active ingredient of Nigella sativa, has been well documented. Current study tested thymoquinone for its antidepressant effect in a Concanavalin A (Con A)-induced depressive-like behavior in BALB/c mice. Thymoquinone successfully protected against Con A-induced behavioral
despair
and anxiety-like behavior. Reduced grooming behavior as a function of Con A treatment, was also reinstated. Underlying mechanism responsible for antidepressant activity of thymoquinone was analyzed by molecular docking. Thymoquinone interacts in halogen-binding pocket (HBP) of serotonin reuptake transporter indicating its potential as serotonin reuptake inhibitor. Results of current study anticipate thymoquinone as a potential antidepressant drug candidate. PRACTICAL APPLICATIONS: Black seeds of Nigella sativa are consumed with traditional and religious reference since centuries. Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against
arthritis
, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes. Considering inflammation as one of central components involved in pathophysiology of major depressive disorder, thymoquinone has been evaluated in current study for its antidepressant potential. Positive results of current study propose thymoquinone as an affordable, natural antidepressant drug candidate with better safety profile than currently available antidepressant regimes. Thymoquinone might provide benefits against inflammation-related sickness behavior that is associated with poorer outcome of clinical depression, thus, paving the way for effective drug development against treatment-resistant depression.
...
PMID:Thymoquinone harbors protection against Concanavalin A-induced behavior deficit in BALB/c mice model. 3261 5